The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 30.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Scale-up Grant Funding for Goliath

9 Oct 2023 07:00

RNS Number : 0438P
Ilika plc
09 October 2023

Ilika plc

("Ilika" or the "Company")

Award of Scale-up Grant Funding for Goliath

Further funding secured from Automotive Transformation Fund, partnered with Mpac Group plc and The UK Battery Industrialisation Centre

Ilika (AIM: IKA), a pioneer in solid state battery technology, announces it is receiving further grant support to scale-up its Goliath pilot production capability. The support is being provided from the Automotive Transformation Fund ('ATF') in a 16-month, £2.7 million collaboration programme, of which Ilika will receive £400,000. In the programme, which commenced on 01 October 2023, Ilika is partnering with Mpac Group plc ('Mpac') (AIM: MPAC) and the UK Battery Industrialisation Centre ('UKBIC').

Mpac is a global engineering and service provider of automation and packaging solutions. They design, precision engineer and manufacture high-speed automation solutions within key sectors including Clean Energy. Ilika and Mpac will work closely to design, build and commission a 1.5MWh solid state battery ('SSB') assembly line capable of delivering Ilika's Goliath SSB prototype large-format pouch cells to automotive OEMs and Tier 1 suppliers. The SSB assembly line is expected to be fully operational at Ilika's facility by the end of H1 2025.

The UKBIC facility, based in Coventry, UK, provides the missing link between battery technology which has proved promising at laboratory or prototype scale and successful mass production. The UKBIC will build on the work carried out in the completed BUS100 programme by undertaking physical trials to produce Ilika's SSB electrodes at GWh scale.

The ATF is a funding programme created to support large-scale industrialisation. Up to £850 million of funding will be invested in developing a high-value end-to-end electrified automotive supply chain in the UK. The fund is highlighted as an important mechanism to reach targets in UK Government's 10-Point Plan for a green industrial revolution and its Transport Decarbonisation Plan.

This collaboration, codenamed Project SiSTEM, will run in parallel with Project HISTORY, announced on 26 January 2023, which will develop prototype automotive A-sample SSBs that will be produced on the scaled Ilika pilot facility.

Graeme Purdy, Ilika CEO, stated: "Project SiSTEM builds upon previous ATF support in Project BUS100 which found that with minor adaptations, Ilika's electrodes could in principle be produced in volume on the UKBIC lines. Project SiSTEM will undertake those physical trials, proving Ilika's technology can be successfully scaled. Our collaboration with Mpac will see the development of a scaled SSB assembly line which will be capable of delivering A-sample automotive pouch cells for testing in 2025. This is an important step in Ilika's roadmap, enabling us to engage closer with OEMs as we start to deliver SSB cells into their test programmes."

Julian Hetherington, Director of the Automotive Transformation Fund, said: "We are delighted to be able to support Ilika's project seeking to validate higher-scale SSB manufacturing processes and which utilises the world-class facilities at UKBIC to demonstrate roll-to-roll coating of solid state materials. SSB technologies have the potential to be transformational in vehicle battery pack design due to their stable nature and open up applications possibilities at higher safe operating temperatures."

Adam Holland, Chief Executive Officer at Mpac Group plc, expressed his enthusiasm: "We are thrilled to announce our new partnership with Ilika and UKBIC after the successful award of the prestigious ATF grant for Project SiSTEM. Mpac is a market leader in complex automation, and we are eager to leverage our expertise in developing a cutting-edge innovative solution that will enable the reliable assembly of solid state batteries. This project not only demonstrates our commitment to technological advancement but also aligns with the UK government's vision for a cleaner and more sustainable world."

Sean Gilgunn, Managing Director of UKBIC, said: "We're delighted to be working with Ilika on trials to support the development of the Company's solid state battery technology. Being able to scale up and demonstrate manufacturing innovation for battery technologies at UKBIC is a valuable resource for the UK's growing battery sector."

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Natasha Ninkov

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Lianne Applegarth

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFSSFWMEDSESS
Date   Source Headline
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.